首頁 > 市場調查報告書 > 醫療設備

體外診斷

市場調查報告書

商品編碼

1937975

全球體外診斷市場規模、佔有率、趨勢和成長分析報告（2026-2034）

Global In Vitro Diagnostics Market Size, Share, Trends & Growth Analysis Report 2026-2034

出版日期: 2026年02月05日 | 出版商:

Value Market Research | 英文 178 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄

體外診斷市場預計將從 2025 年的 931.1 億美元成長到 2034 年的 1,310.4 億美元，2026 年至 2034 年的複合年成長率為 3.87%。

由於慢性病發病率上升以及對早期、精準診斷解決方案的需求日益成長，體外診斷（IVD）市場預計將迎來顯著成長。體外診斷檢測（IVD）利用血液、尿液和組織等檢體，在疾病的檢測、後續觀察和管理中發揮至關重要的作用。隨著醫療機構越來越重視個人化和預防性醫療，對先進體外診斷技術的需求預計將會增加。分子診斷、就地檢驗和自動化領域的技術創新正在提高診斷過程的準確性和效率，從而進一步推動市場成長。

體外診斷（IVD）領域的科技進步也在塑造著該市場的未來。快速檢測方法的開發以及人工智慧（AI）和機器學習在數據分析中的應用，正在徹底改變診斷方式。這些創新使醫療專業人員能夠及時獲得檢測結果，從而加快決策速度，並改善患者預後。此外，隨著患者尋求便捷的診斷解決方案，居家檢測和遠端醫療的趨勢也可能對體外診斷市場產生正面影響。

此外，新興經濟體醫療基礎設施的擴張預計將對體外診斷市場產生積極影響。亞太和拉丁美洲等地區醫療服務可近性的提高以及對高品質診斷服務需求的成長將推動體外診斷產品的消費。專注於開發創新且經濟高效的診斷解決方案，並針對特定區域需求量身定做的公司，將更有利於獲得市場佔有率。隨著體外診斷市場的不斷發展，技術進步、監管變化和消費者偏好轉變之間的相互作用預計將創造一個充滿活力、成長機會和創新空間的市場環境。

區域分析
北美市場分析、洞察與預測
- 美國
- 加拿大
- 墨西哥
歐洲市場分析、洞察與預測
- 英國
- 法國
- 德國
- 義大利
- 俄羅斯
- 其他歐洲國家
亞太市場分析、洞察與預測
- 印度
- 日本
- 韓國
- 澳洲
- 東南亞
- 其他亞太國家
拉丁美洲市場分析、洞察與預測
- 巴西
- 阿根廷
- 秘魯
- 智利
- 其他拉丁美洲國家
中東和非洲市場分析、洞察與預測
- 沙烏地阿拉伯
- UAE
- 以色列
- 南非
- 其他中東和非洲國家

第9章競爭情勢

最新趨勢
公司分類
供應鏈和銷售管道合作夥伴（根據現有資訊）
市場佔有率和市場定位分析（基於現有資訊）
供應商格局（基於現有資訊）
策略規劃

第10章：公司簡介

主要公司的市佔率分析
公司簡介
- Roche Diagnostics
- Abbott Laboratories
- Siemens Healthineers
- Danaher Corporation
- Thermo Fisher Scientific
- Becton, Dickinson And Company（BD）
- Bio-Rad Laboratories
- BioMAfA（C）Rieux
- Qiagen
- Hologic
- Sysmex Corporation
- Ortho Clinical Diagnostics
- Agilent Technologies
- Illumina

簡介目錄

Product Code: VMR11218520

The In Vitro Diagnostics Market size is expected to reach USD 131.04 Billion in 2034 from USD 93.11 Billion (2025) growing at a CAGR of 3.87% during 2026-2034.

The in vitro diagnostics (IVD) market is poised for substantial growth, driven by the increasing prevalence of chronic diseases and the rising demand for early and accurate diagnostic solutions. IVD tests, which are performed on samples such as blood, urine, and tissue, play a critical role in disease detection, monitoring, and management. As healthcare providers increasingly prioritize personalized medicine and preventive care, the demand for advanced IVD technologies is expected to rise. Innovations in molecular diagnostics, point-of-care testing, and automation are enhancing the accuracy and efficiency of diagnostic processes, further propelling market growth.

Technological advancements in IVD are also shaping the future of this market. The development of rapid testing methods and the integration of artificial intelligence and machine learning in data analysis are revolutionizing the way diagnostics are performed. These innovations enable healthcare professionals to obtain timely results, facilitating quicker decision-making and improved patient outcomes. Additionally, the growing trend towards home-based testing and telemedicine is likely to influence the IVD market positively, as patients seek convenient and accessible diagnostic solutions.

Moreover, the expansion of healthcare infrastructure in emerging economies is expected to positively impact the in vitro diagnostics market. As access to healthcare improves and the demand for quality diagnostic services increases in regions such as Asia-Pacific and Latin America, the consumption of IVD products will rise. Companies that focus on developing innovative and cost-effective diagnostic solutions tailored to specific regional needs will be well-positioned to capture market share. As the IVD market evolves, the interplay of technological advancements, regulatory changes, and shifting consumer preferences will create a dynamic environment ripe with opportunities for growth and innovation.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product Type

Instruments
Reagents
Software
Services

By Technology

Immunoassay
Clinical Chemistry
Molecular Diagnostics
Hematology
Microbiology
Coagulation
Others

By Application

Infectious Diseases
Oncology
Cardiology
Nephrology
Autoimmune Diseases
Others

By End-User

Hospitals
Diagnostic Laboratories
Academic and Research Institutes
Others

COMPANIES PROFILED

Roche Diagnostics, Abbott Laboratories, Siemens Healthineers, Danaher Corporation, Thermo Fisher Scientific, Becton, Dickinson and Company BD, BioRad Laboratories, bioMrieux, Qiagen, Hologic, Sysmex Corporation, Ortho Clinical Diagnostics, Agilent Technologies, Illumina

We can customise the report as per your requriements

Chapter 1. PREFACE

1.1. Market Segmentation & Scope
1.2. Market Definition
1.3. Information Procurement
- 1.3.1 Information Analysis
- 1.3.2 Market Formulation & Data Visualization
- 1.3.3 Data Validation & Publishing
1.4. Research Scope and Assumptions
- 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

2.1. Market Snapshot
2.2. Segmental Outlook
2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

3.1. Market Lineage Outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Value Chain Analysis
3.4. Regulatory Framework
- 3.4.1 Standards & Compliance
- 3.4.2 Regulatory Impact Analysis
3.5. Market Dynamics
- 3.5.1 Market Drivers
- 3.5.2 Market Restraints
- 3.5.3 Market Opportunities
- 3.5.4 Market Challenges
3.6. Porter's Five Forces Analysis
3.7. PESTLE Analysis

Chapter 4. GLOBAL IN VITRO DIAGNOSTICS MARKET: BY PRODUCT TYPE 2022-2034 (USD MN)

4.1. Market Analysis, Insights and Forecast Product Type
4.2. Instruments Estimates and Forecasts By Regions 2022-2034 (USD MN)
4.3. Reagents Estimates and Forecasts By Regions 2022-2034 (USD MN)
4.4. Software Estimates and Forecasts By Regions 2022-2034 (USD MN)
4.5. Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL IN VITRO DIAGNOSTICS MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

5.1. Market Analysis, Insights and Forecast Technology
5.2. Immunoassay Estimates and Forecasts By Regions 2022-2034 (USD MN)
5.3. Clinical Chemistry Estimates and Forecasts By Regions 2022-2034 (USD MN)
5.4. Molecular Diagnostics Estimates and Forecasts By Regions 2022-2034 (USD MN)
5.5. Hematology Estimates and Forecasts By Regions 2022-2034 (USD MN)
5.6. Microbiology Estimates and Forecasts By Regions 2022-2034 (USD MN)
5.7. Coagulation Estimates and Forecasts By Regions 2022-2034 (USD MN)
5.8. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL IN VITRO DIAGNOSTICS MARKET: BY APPLICATION 2022-2034 (USD MN)

6.1. Market Analysis, Insights and Forecast Application
6.2. Infectious Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
6.3. Oncology Estimates and Forecasts By Regions 2022-2034 (USD MN)
6.4. Cardiology Estimates and Forecasts By Regions 2022-2034 (USD MN)
6.5. Nephrology Estimates and Forecasts By Regions 2022-2034 (USD MN)
6.6. Autoimmune Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
6.7. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL IN VITRO DIAGNOSTICS MARKET: BY END-USER 2022-2034 (USD MN)

7.1. Market Analysis, Insights and Forecast End-user
7.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
7.3. Diagnostic Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
7.4. Academic and Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
7.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL IN VITRO DIAGNOSTICS MARKET: BY REGION 2022-2034(USD MN)

8.1. Regional Outlook
8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 8.2.1 By Product Type
- 8.2.2 By Technology
- 8.2.3 By Application
- 8.2.4 By End-user
- 8.2.5 United States
- 8.2.6 Canada
- 8.2.7 Mexico
8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 8.3.1 By Product Type
- 8.3.2 By Technology
- 8.3.3 By Application
- 8.3.4 By End-user
- 8.3.5 United Kingdom
- 8.3.6 France
- 8.3.7 Germany
- 8.3.8 Italy
- 8.3.9 Russia
- 8.3.10 Rest Of Europe
8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 8.4.1 By Product Type
- 8.4.2 By Technology
- 8.4.3 By Application
- 8.4.4 By End-user
- 8.4.5 India
- 8.4.6 Japan
- 8.4.7 South Korea
- 8.4.8 Australia
- 8.4.9 South East Asia
- 8.4.10 Rest Of Asia Pacific
8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 8.5.1 By Product Type
- 8.5.2 By Technology
- 8.5.3 By Application
- 8.5.4 By End-user
- 8.5.5 Brazil
- 8.5.6 Argentina
- 8.5.7 Peru
- 8.5.8 Chile
- 8.5.9 South East Asia
- 8.5.10 Rest of Latin America
8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 8.6.1 By Product Type
- 8.6.2 By Technology
- 8.6.3 By Application
- 8.6.4 By End-user
- 8.6.5 Saudi Arabia
- 8.6.6 UAE
- 8.6.7 Israel
- 8.6.8 South Africa
- 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

9.1. Recent Developments
9.2. Company Categorization
9.3. Supply Chain & Channel Partners (based on availability)
9.4. Market Share & Positioning Analysis (based on availability)
9.5. Vendor Landscape (based on availability)
9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL IN VITRO DIAGNOSTICS INDUSTRY

10.1. Top Companies Market Share Analysis
10.2. Company Profiles
- 10.2.1 Roche Diagnostics
- 10.2.2 Abbott Laboratories
- 10.2.3 Siemens Healthineers
- 10.2.4 Danaher Corporation
- 10.2.5 Thermo Fisher Scientific
- 10.2.6 Becton, Dickinson And Company (BD)
- 10.2.7 Bio-Rad Laboratories
- 10.2.8 BioMAfA(C)Rieux
- 10.2.9 Qiagen
- 10.2.10 Hologic
- 10.2.11 Sysmex Corporation
- 10.2.12 Ortho Clinical Diagnostics
- 10.2.13 Agilent Technologies
- 10.2.14 Illumina